Eve Kretschmer

Eve Kretschmer currently serves as the Executive Director of Oncology R&D Strategy at AstraZeneca, a position held since July 2024. Previously, Eve held the role of VP of Corporate Development at Precede Biosciences from February 2023 to July 2024, and prior to that, was the Head of Corporate Strategy & Development at Generate Biomedicines, Inc. Eve has extensive experience at bluebird bio, where multiple roles, including VP of Strategy & Transformation and VP of Commercial Strategy & Operations, were undertaken. Prior consulting roles include positions at Boston Consulting Group and Booz & Company. Eve's career began in strategy at Lake Partners Strategy Consultants and Intellectual Ventures, contributing to significant licensing deals. Educational credentials include an MBA from Columbia Business School with a focus on Healthcare and Pharmaceutical Management, as well as a BA in Neuroscience from Dartmouth College.